Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fang Ning

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 12, 2019
The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell CarcinomaWen-Hao Xu, Shen-Nan Shi, Jun Wang, et al.
NPJ Precision Oncology|December 11, 2023
A deep learning model, NAFNet, predicts adverse pathology and recurrence in prostate cancer using MRIsWei-Jie Gu, Zheng Liu, Yun-Jie Yang, et al.
Aging|September 8, 2019
Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironmentWen-Hao Xu, Yue Xu, Jun Wang, et al.
Plos One|April 30, 2015
MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate CancerGui-Ming Zhang, Chun-Yang Bao, Fang-Ning Wan, et al.
Plos One|December 20, 2016
An Analysis of EGFR Mutations among 1506 Cases of Non-Small Cell Lung Cancer Patients in Guangxi, ChinaWen-E Wei, Nai-Quan Mao, Shu-Fang Ning, et al.
Journal of Digestive Diseases|June 1, 2026
Multidimensional Optimization of Small Bowel Capsule Endoscopy With Transcutaneous Electrical Acustimulation: A Randomized Controlled TrialYi Long Liu, Bei Fang Ning, Ya Nan Mao, et al.
Cancer Research|September 30, 2010
Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinomaBei-Fang Ning, Jin Ding, Chuan Yin, et al.
International Journal of Biological Macromolecules|January 9, 2026
Tumor-associated macrophage-specific SERPING1 contributes to M1-phenotype transition and suppress colorectal cancer tumorigenesis via NF-κB pathwayHao-Tang Wei, Xiao-Ling Luo, Feng Lv, et al.
Hepatology (Baltimore, Md.)|June 19, 2013
Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 regionChuan Yin, Pei-Qin Wang, Wen-Ping Xu, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 24, 2026
Artesunate overcomes oxaliplatin resistance in colorectal cancer by inducing ferroptosis through inhibition of the CDK5/Nrf2/GPX4 pathwayFeng Lv, Xiao-Huan Li, Si-Qi Li, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 12, 2019
The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell CarcinomaWen-Hao Xu, Shen-Nan Shi, Jun Wang, et al.
NPJ Precision Oncology|December 11, 2023
A deep learning model, NAFNet, predicts adverse pathology and recurrence in prostate cancer using MRIsWei-Jie Gu, Zheng Liu, Yun-Jie Yang, et al.
Aging|September 8, 2019
Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironmentWen-Hao Xu, Yue Xu, Jun Wang, et al.
Plos One|April 30, 2015
MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate CancerGui-Ming Zhang, Chun-Yang Bao, Fang-Ning Wan, et al.
Plos One|December 20, 2016
An Analysis of EGFR Mutations among 1506 Cases of Non-Small Cell Lung Cancer Patients in Guangxi, ChinaWen-E Wei, Nai-Quan Mao, Shu-Fang Ning, et al.
Journal of Digestive Diseases|June 1, 2026
Multidimensional Optimization of Small Bowel Capsule Endoscopy With Transcutaneous Electrical Acustimulation: A Randomized Controlled TrialYi Long Liu, Bei Fang Ning, Ya Nan Mao, et al.
Cancer Research|September 30, 2010
Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinomaBei-Fang Ning, Jin Ding, Chuan Yin, et al.
International Journal of Biological Macromolecules|January 9, 2026
Tumor-associated macrophage-specific SERPING1 contributes to M1-phenotype transition and suppress colorectal cancer tumorigenesis via NF-κB pathwayHao-Tang Wei, Xiao-Ling Luo, Feng Lv, et al.
Hepatology (Baltimore, Md.)|June 19, 2013
Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 regionChuan Yin, Pei-Qin Wang, Wen-Ping Xu, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 24, 2026
Artesunate overcomes oxaliplatin resistance in colorectal cancer by inducing ferroptosis through inhibition of the CDK5/Nrf2/GPX4 pathwayFeng Lv, Xiao-Huan Li, Si-Qi Li, et al.
Pageof 15